Assessment of anti-cancerous activity of Argemone mexicana by its leaf extracts on skin and colon cancer cell lines using network pharmacology in conjunction with research into the regulatory patterns of TNF-α and NF-kB. The gene discussed is NFKB1; the disease is malignant colon neoplasm.